Dual‐Targeted Pt@Ce‐ MOF Nanoplatform Enhances Radiotherapy Efficacy via Tumor‐Specific Delivery and Mitochondrial Dysfunction in Breast Cancer
Biopolymers · 2025
DOI: 10.1002/bip.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biopolymers, 2025. Verfasst von Yanyan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Platinum, Mitochondria, Cerium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Anhui Educational Committee.
Abstract (Originalsprache)
The development of multifunctional nanoplatforms capable of enhancing the efficacy and precision of cancer radiochemotherapy remains a significant clinical need. Here, we report a dual‐targeted cerium‐based metal–organic framework nanoplatform (Pt@Ce‐MOF‐RGD/FA) designed for synergistic radiosensitization and chemotherapeutic delivery in breast cancer. The Ce‐MOF core acts as a reactive oxygen species (ROS) amplifier under radiotherapy, while encapsulated cisplatin (Pt) serves as a chemotherapeutic agent. Surface modification with RGD and folic acid (FA) enables active targeting of tumor cells via αvβ3 integrin and folate receptor pathways. Comprehensive physicochemical characterization confirmed successful construction of the nanocomposite. In vitro, Pt@Ce‐MOF‐RGD/FA exhibited potent cytotoxicity, enhanced cellular uptake, inhibition of tumor cell migration, and robust ROS generation and mitochondrial membrane depolarization. In vivo fluorescence imaging demonstrated superior tumor accumulation of the dual‐ligand‐modified formulation. Under radiotherapy, Pt@Ce‐MOF‐RGD/FA achieved significant tumor growth suppression in a 4T1 murine breast cancer model without inducing systemic toxicity, as confirmed by blood biochemistry, hematological analysis, and histopathology. Collectively, this work presents a rationally engineered nanoplatform with precise tumor targeting, efficient drug delivery, and enhanced radiosensitization, offering a promising strategy for safe and effective cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
ORCID-Profile: Yanyan Wang
Förderung
- Anhui Educational Committee
Zitieren
APA
Wang, Y., Han, X., Zhang, S., Wang, L., Sun, S., Xue, C., & Yao, T. (2025). Dual‐Targeted Pt@Ce‐ MOF Nanoplatform Enhances Radiotherapy Efficacy via Tumor‐Specific Delivery and Mitochondrial Dysfunction in Breast Cancer. Biopolymers. https://doi.org/10.1002/bip.70054
Vancouver
Wang Y, Han X, Zhang S, Wang L, Sun S, Xue C, et al. Dual‐Targeted Pt@Ce‐ MOF Nanoplatform Enhances Radiotherapy Efficacy via Tumor‐Specific Delivery and Mitochondrial Dysfunction in Breast Cancer. Biopolymers. 2025. doi:10.1002/bip.70054
BibTeX
@article{Wang2025,
author = {Wang, Yanyan and Han, Xinxin and Zhang, Song and Wang, Lin and Sun, Siyu and Xue, Chun and Yao, Tingjing},
title = {Dual‐Targeted Pt@Ce‐ MOF Nanoplatform Enhances Radiotherapy Efficacy via Tumor‐Specific Delivery and Mitochondrial Dysfunction in Breast Cancer},
journal = {Biopolymers},
year = {2025},
doi = {10.1002/bip.70054}
}
EUVIMED